Vivace Therapeutics
PrivateLast Round
Series D
Mar 12, 2025
Total Funding Raised
$105M
Company Overview
Vivace Therapeutics is a biotechnology company focused on small molecule drug discovery and development, dedicated to creating innovative therapies for cancer treatment by harnessing cutting-edge research and novel pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivace Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Vivace Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 12, 2025 | ||||
| Series C | Dec 16, 2020 | ||||
| Series B | Jun 28, 2017 | ||||
| Series A | Jan 20, 2015 |
Vivace Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series D |
| Boxer Capital | Series C |
| BioInnovation Capital | Series B |
| Sequoia Capital | Series C |
| Cenova Capital | Series C, Series D, Series B |
| Canaan Partners | Series C, Series B, Series D, Series A |
| HongShan | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2025
$35M round completed.
Vivace Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivace Therapeutics's valuation, stock price, and market status.
